期刊文献+

注射用重组葡激酶的中试研究 被引量:6

The Pilot Studies of Recombinant Staphylokinase for Injection
下载PDF
导出
摘要 在已获得了高效表达重组葡激酶工程菌的基础上建立了快速、高效的注射用重组葡激酶中试生产规程。工程菌经机械破碎和离心后,上清液经硫酸铵分级沉淀,一步凝胶过滤和一步阴离子交换即可获得高纯度、高活性的半成品,加入稳定剂后过滤除菌、分装、冻干即得成品。蛋白质回收率和活性回收率均为40%以上,由于选用径向色谱柱,色谱参数可直接放大至工业化生产。 An effective and rapid pilot production procedure of recombinant staphylokinnase was established on the basis of the construction of the high expression engineering bacterium. After a step of gel filtration and a step of ion exchange, the qualified semi finished product of recombinant staphylokinase for injection was obtained. The recoveries of both proteins and activity were over 40%. Moreover, as the radial flow column in ion exchange chromatography was employed, the procedure was easy to be scaled up to the industrial production of r SAK.
出处 《高技术通讯》 EI CAS CSCD 1998年第1期45-48,共4页 Chinese High Technology Letters
基金 863计划资助
关键词 重组葡激酶 中试研究 SAK 葡激酶 Recombinant staphylokinase, Pilot study
  • 相关文献

参考文献2

同被引文献33

  • 1汤其群,张小璇,于敏,宋后燕.重组葡激酶(r-Sak)的分离、纯化和结晶[J].药物生物技术,1997,4(1):1-4. 被引量:15
  • 2Ding H,上海医科大学学报,1992年,19卷,增,38页 被引量:1
  • 3宋后燕,ZL94112105 一种重组葡激酶的制备方法. 被引量:1
  • 4Bode C, Smaling R W. Berg G, et al. Randomized comparison of coronary thrombolysis achieved with double bolus reteplase(recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in pa tients with acute myocardial infarction[J ] Circulation, 1996,94:891. 被引量:1
  • 5Keyt B A, Paoni N F, Bennett W F, et al. A faster acting and move potent form of tissue plasminogen activator [J ] . Pro Natl Acad Sci USA, 1994,91:3670. 被引量:1
  • 6Thomas G R, Thibodeaux H, Bennett W F, et al. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding [ J ] . Stroke,1994, 25: 2072. 被引量:1
  • 7Larsen G R, Timony G A, Stoudemire J B, et al. Protein engineering of novel plasminogen activators with increased thrombolytic potency in rabbits relative to activase [J]. J Biol Chem, 1991,266:8156. 被引量:1
  • 8Ross A M. New plasminogen activators: a clinical review [J ].Clin Cardiol, 1999, 22:165. 被引量:1
  • 9Lijnen H R, Nelles L, Holmes W E, et al. Biochemical and thrombolyric properties of a low molecular weight form (comprising Leu 144 through Leu 411) of recombinant single-chain urokinase-type plasminogen activator [J]. JBiol Chem, 1988,263:5394. 被引量:1
  • 10Adams G S, Griffin L A, Nachajko W R, et al. A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor [ J ]. J Biol Chem,1991, 266: 8476. 被引量:1

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部